Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy

Tina J. Hieken, Judy C. Boughey, Amy C. Degnim, Katrina N. Glazebrook, Tanya L. Hoskin

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
JournalAnnals of surgical oncology
DOIs
StateAccepted/In press - 2022

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this